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CASE PRESENTATION
A 35-year-old Hispanic male on hemodialysis for
end-stage renal disease (ESRD) secondary to diabetic
nephropathy was admitted with chest pain and shortness
of breath. The chest pain was localized to the midline,
without any radiation or diaphoresis and was present at
rest. The patient was bed-bound due to bilateral
below-knee amputations. He had recurrent episodes of
chest pain and shortness of breath in the past 3 months
for which he was hospitalized. During these admissions,
his cardiac enzymes were within normal limits. A stress
test performed recently was technically limited, but
showed a small inferior defect with normal left ventricular
function. He had a past history of type I diabetes mellitus
since the age of 10. Subsequently, he developed
peripheral neuropathy, blindness secondary to
retinopathy, nephropathy with ESRD, and underwent
below-knee amputation of left and right limbs for severe
peripheral vascular disease 6 and 12 years before,
respectively. He had no history of cerebrovascular
accident. He also had a past history of hypertension and
hypercholesterolemia. His medications included lisinopril,
metoprolol, nifedipine, aspirin, clopidogrel, and insulin. He
had a strong family history of diabetes, with his mother
and brother being diabetes patients. On physical
examination, he was lethargic, afebrile with a blood
pressure of 170/86 mm Hg, heart rate of 70 beats per
minute, respiratory rate of 14 breaths per minute with an
oxygen saturation of 97% on 2 l of supplemental oxygen,
and jugular venous pressure of 14 cm. Cardiac
examination revealed audible S3 and S4. Respiratory
examination revealed fine rales at the left lung base and
decreased breath sounds at the right lung base. His
tunneled catheter site on the right side of the neck was
clean, with no tenderness or erythema. The remainder of
the systemic examination was unremarkable.
His hematology, biochemistry, and cardiac enzyme values are
summarized in Table 1. His electrocardiogram showed new
T wave inversions in V5 and V6, but his cardiac enzymes
were within normal limits. His chest X-ray showed mild
cardiomegaly and pulmonary edema. His serial calcium–
phosphorus levels are shown in Figure 1.
CLINICAL DIAGNOSIS
A clinical diagnosis of unstable angina with diffuse vascular
calcification and underlying coronary artery disease and New
York Heart Association class IV with congestive heart failure
was made.
CLINICAL FOLLOW-UP
Acute myocardial infarction was ruled out by serial cardiac
enzymes. A dobutamine stress echo was done, which showed
an increase in inferior wall ischemia as well as a depressed
ejection fraction of 40% when compared to his previous
stress test. A computed tomography (CT) scan performed
with and without contrast showed calcification of the
coronary arteries and greater vessels in the abdomen
(Figure 2c and d). Coronary angiogram revealed diffuse
calcified coronary artery lesions with 80% stenosis of the
proximal left anterior descending artery, 90% stenosis of
the distal left anterior descending artery, 90% stenosis of
obtuse marginal 1, and 80% stenosis of obtuse marginal 2
(Figure 2a and b). In view of the discrepancy between the
coronary vessels affected (left-sided) and the distribution
of ischemia on the dobutamine stress test (inferior), a
possibility of extensive atherosclerosis of the small coronary
arteries was considered and medical management was
recommended. The patient’s chest pain improved with
aggressive volume removal at dialysis, blood pressure control,
and hydromorphone treatment. He was discharged home
with arrangements for continued outpatient dialysis. He was
found dead at home 1 month later.
DISCUSSION
This patient on hemodialysis presented with diffuse vascular
calcification associated with severe coronary and peripheral
vascular disease and had a fatal outcome at a relatively
young age. This case raises several complex issues with
respect to the management of young dialysis patients with
vascular calcification. These include coronary artery disease,
dialysis access, hypertension, and potential management
strategies.
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Etiopathogenesis and biology of vascular calcification
The earliest reports of vascular calcification date back to
1855, when Virchow1 suggested that calcium deposits
contribute to ‘ossification’ of the vasculature. Since then,
several studies have explored the issue of vascular calcifica-
tion in patients with chronic kidney disease and ESRD.
Vascular calcification is an active cell-mediated process that is
made worse by the disorders of mineral metabolism. An
important pathogenic mechanism described for vascular
calcification is the osteogenic differentiation of vascular
smooth muscle cells into osteoblast-like cells that lay down
a collagenous extracellular matrix into which minerals are
deposited.2
Vascular calcification in patients with chronic kidney
disease can occur in either the intima or media of the vessel
wall. Medial calcification, also known as Monckeberg’s
medial calcific sclerosis, is more frequently observed in
patients with diabetes. It is considered a strong prognostic
marker for all-cause and cardiovascular mortality in
hemodialysis patients, independent of classical atherogenic
factors.3 On the other hand, intimal calcification is more
common with advancing age and is observed in patients with
hypertension, diabetes, and dyslipidemia and is associated
with atherosclerotic plaques. Whereas medial calcification
manifests with arterial stiffening that accounts for reduced
vascular distensibility and increased vascular resistance in
dialysis patients, intimal calcification compromises flow by
occluding the lumen. Although both forms of vascular
calcification are observed in patients on dialysis, adolescents
and young adults are especially susceptible to medial
calcification.4
There are several risk factors for accelerated atherosclerosis
and vascular calcification in dialysis patients. Recent studies
have implicated abnormalities in serum calcium, serum
phosphate, and calcium phosphate product as the leading
cause of vascular calcification in these patients. These could be
partly contributed by secondary hyperparathyroidism, use of
calcium-based phosphate binders, and vitamin D. Patients
also have decreased excretion of calcium in the urine and
abnormal bone remodeling, both of which contribute to the
high calcium load with subsequent calcification. Other risk
factors that promote vascular calcification include hyperten-
sion, glucose intolerance/diabetes, dyslipidemia, hyperhomo-
cysteinemia, early complement activation, nicotine exposure
(the half-life of nicotine is prolonged in uremic patients), and
prolonged time on dialysis.5 Newer studies have suggested a
role of several other factors in accelerated vascular calcifica-
tion such as C-reactive protein, low fetuin-A levels, and
malnutrition.6,7 Recent data on fetuin-A suggest the associa-
tion of low serum fetuin-A with increased arterial and valvular
calcification scores,8,9 and increased fetuin-A levels with
reduced cardiovascular and noncardiovascular mortality.10,11
Clinical implications of vascular calcification
Both vascular and valvular calcifications are associated with
increased cardiovascular mortality and morbidity.12,13 Over
Table 1 | Laboratory parameters of the index patient at the
time of admission
Investigation Result (reference range)
Serum chemistry
Sodium 134.0 mmol l1 (136–142 mmol l1)
Potassium 6.6 mmol l1 (3.5–5.0 mmol l1)
Calcium 8.3 mmol l1 (8.8–10.5 mmol l1)
Creatinine 7.2 mg per 100 ml (0.7–1.3 mg per 100 ml)
Blood urea nitrogen 66.0 mg per 100 ml (9–25 mg per 100 ml)
Blood glucose 87.0 mg per 100 ml (54–118 mg per 100 ml)
HgbA1C 4.9% (4.2–5.8%)
Blood count
Hemoglobin 12.5 g per 100 ml (13.5–18 g per 100 ml)
WBC 8.27kml1 (4–10kml1)
Platelets 235.0kml1 (150–450 kml1)
Hematocrit 40.6% (40–54%)
Cardiac enzymes
CK 71.0 U l1 (41–266 U l1)
CK-MB 2.6 U l1 (0.0–5.0 U l1)
Troponin-I Below assay (0.00–0.10 ng ml1)
Lipid panel
Cholesterol 94 mg per 100 ml (140–199 mg per 100 ml)
Triglycerides 46 mg per 100 ml (35–150 mg per 100 ml)
LDL 38 mg per 100 ml (50–129 mg per 100 ml)
HDL 47 mg per 100 ml (40–60 mg per 100 ml)
CK, creatinine kinase; CK-MB, a CK isoenzyme; HDL, high-density lipoprotein; LDL,
low-density lipoprotein; WBC, white blood cells.
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Figure 1 | Graph showing the trends in serum calcium, serum
phosphorus, and calculated calcium–phosphorus product over 2
months period.
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the last several years, it has been recognized that aortic
calcification occurs in ESRD patients about 10–20 years
earlier than in the general population; indeed, aortic
calcification is an independent risk factor for mortality in
these patients.14 Wayhs et al.15 found that extensive coronary
calcification corresponded with a high rate of coronary death
or myocardial infarction. However, the cause and effect
relationship between vascular calcification and cardiovascular
events remains unclear, as vascular calcification is often
considered a marker of atherosclerotic burden. The pro-
atherogenic state of dialysis patients may also be worsened by
impaired endothelium-dependent vasodilatation, which may
increase susceptibility to the development of atherosclerosis
and thrombosis. Atherosclerotic coronary plaques in patients
with ESRD have a high complication rate such as plaque
instability and rupture, which occur as a result of abnormal
plaque composition and are characterized by marked
calcification and increased media thickness. Although the
size of atheromatous plaques in uremic patients does not
differ from nonuremic subjects, they are characterized by
higher calcium content.16
Diffuse vascular disease among young patients, in
pediatric to young adult age group, raises special concerns
on cardiovascular outcomes. A study by Goodman et al.5
suggested that diffuse vascular calcification is common by the
third decade, progresses rapidly, and corresponds with the
duration of hemodialysis. In their study, 14 of 16 patients
between the age of 20 and 30 years had vascular calcification,
as detected by electron beam CT. Vascular calcification score
nearly doubled in 10 patients when followed over 2 years. In
another study by Milliner et al.,17 36% of the patients had
systemic calcification with preponderance to blood vessels.
a b
c d
Figure 2 | Coronary angiography and CT scan of the chest and abdomen of the index patient. Coronary angiography showing gross
stenosis/occlusion of (a) the coronary vasculature and (b) calcified coronary vessels. (c) Plain CT scan of the chest showing calcification of the
vessels along the interventricular septum and descending aorta. (d) Plain CT scan of the abdomen showing calcification of renal and mesenteric
vessels.
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Oh et al.18 noted coronary artery calcification in 92% of 39
young adults aged 19–39 years, with chronic renal failure
duration ranging from 7 to 34 years and cumulative dialysis
duration of 0–22 years.
Apart from coronary artery disease, vascular calcification
is also associated with technical failure of arteriovenous graft
and arteriovenous fistula. In a study by Lockhart et al.,19
three out of six patients with moderate to severe pelvic
calcification (grade 3–5) had technical thigh graft failure as
compared to none among 26 patients with absent or mild
pelvic calcification (grade 1–2). Germane to this case
presentation, vascular calcification also significantly affects
the technical feasibility of coronary interventions and can be
associated with postintervention complications and hence
portends poor survival.20
Medial calcification is also associated with increased
stiffness of vessels and reduced vascular compliance, leading
to increased pulse pressure, reduced coronary perfusion, and
abnormal autonomic and endothelial vasomotor function.21
Diagnosis of vascular calcification
The last several years have witnessed a number of screening
techniques to detect vascular calcification. These include
plain X-rays, echocardiogram, ultrasonography, intravascular
ultrasonography, and CT scans. Plain X-rays document
macroscopic calcifications and the pattern may sometimes
suggest medial calcification (linear tram track-radio-opaque
lesions are visible along the course of an artery) or intimal
calcification (patchy and irregular radio-opaque lesions).
Echocardiogram often delineates calcification of the cardiac
valves, whereas ultrasound is used in conjunction with X-rays
to provide qualitative and semiquantitative assessment of
vascular calcification. A more refined approach is the use of
intravascular ultrasound for the detection of calcification.
However, these techniques are not useful to quantify the
extent of calcification. Newer modalities such as electron
beam CT and multislice CT accurately evaluate and quantify
vascular calcification, although they cannot distinguish
between medial and intimal calcification. Matsuoka et al.22
followed 104 chronic hemodialysis patients for an average of
43 months after a screening electron beam CT and reported a
significantly lower 5-year cumulative survival for patients
with a score more than 200 than for those with a score less
than 200 (67.9 versus 84.2%).
Prevention and treatment of vascular calcification
Various measures have been suggested that limit the
progression of vascular calcification. The most important
suggested measure is the substitution of calcium-containing
phosphate binders with sevelamer. In a study by Block et al.,23
sevelamer was reported to be associated with significantly
slower rates of progression of vascular calcification.
Both coronary artery bypass graft and percutaneous
coronary intervention are associated with increased incidence
of post-procedural complications.20 With advances in
technology, several newer modalities have been studied with
varying success rates. Bilodeau et al.24 studied the safety and
efficacy of excimer laser to facilitate angioplasty in 100
calcified lesions and reported technical success in 87 lesions
(92%), procedural success in 88 lesions (93%), and clinical
success in 82 lesions (86%). Another technique is the use of
‘Buddy’ wire, that is, using an additional coronary guide wire
along with the one being used to advance balloons, stents, or
other devices. It improves the balloon or stent support and
also provides the guiding catheter stability. Another study
suggested that combination of rotablation and implantation
of drug eluting stent had a favorable effect on clinical and
angiographic outcomes compared to rotablation followed by
implantation of bare metal stent in patients with heavily
calcified lesions.25 Efficacy has also been reported with the
use of sirolimus-eluting stents.26 Other treatment modalities
tried include directional coronary atherectomy that has been
used successfully in proximal anterior descending lesions and
bifurcation lesions, rotational atherectomy that successfully
treats calcific and diffusely diseased coronary vessels and
ostial stenosis, and vascular brachytherapy that has been
successful in treating re-stenosis occurring within stent.
However, these procedures have not been studied in dialysis
population in large scale.
The role of renal transplantation in vascular calcification is
a controversy. With renal transplantation, abnormalities of
mineral metabolism normalize, 1a-hydroxylase activity is
restored, and parathyroid hormone levels come down. With
these changes, a rapid reduction in vascular calcification is
expected. However, Oschatz et al.27 reported that coronary
artery calcification assessed by multidetector CT increased
significantly in the first 6 months after transplant, stabilizing
only after 12 months of follow-up.
CONCLUSION
This case illustrates the diffuse nature of vascular calcification
observed in dialysis patients. Although diabetes and hyper-
tension are widely prevalent in dialysis patients and
contribute to accelerated atherosclerosis and vascular calci-
fication, the uremic milieu itself appears to be a major risk
factor for atherosclerosis and diffuse vascular calcification.
Tragically, diffuse vascular calcification, a ‘bete noir’ or bane
in the life of dialysis patients, is associated with devastating
outcomes.
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